Lanashield Skin Barrier recalled over current good manufacturing practice deviations
Blossom Pharmaceuticals is recalling 9600 containers of Lanashield Skin Barrier over current good manufacturing practice deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record cites current good manufacturing practice deviations with no stated product defect or reported harm.
Plain-English summary
Lanashield Skin Barrier, 4 oz (113 g), made in India, UPC 616784126319, manufactured for Dynarex Corporation of Orangeburg, New York, is being recalled.
The reason given in the enforcement record is cGMP deviations.
The recall covers 9600 containers from lots A162301, expiry 9/26; A162401, expiry 4/27; and A162202, expiry 11/25. Distribution was nationwide in the USA. The FDA has classified the action as Class II.
The record cites manufacturing practice deviations without describing a specific product defect, and states no injuries. Customers should follow the firm's instructions.
The recalled product
- Product
- Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.
- Manufacturer
- Blossom Pharmaceuticals
- Category
- Drug — Skin barrier
- Affected units
- 9,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: A162301
- Exp. Date 9/26
- A162401
- Exp. Date 4/27 & A162202
- Exp. Date 11/25.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by Blossom Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Blossom Pharmaceuticals
See all →- ModerateClotrimazole cream, 1 ounce size, recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateWound hydrogel recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateDynashield Skin Protectant, 16 ounce size, recalled over manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateWeCare zinc oxide ointment recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateNivagen zinc oxide ointment recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19